Bottom line
UMMA vs JGQYX: the short answer
UMMA (Wahed Dow Jones Islamic World ETF) and JGQYX (Jensen Global Quality Growth Fund) are both etfs.
But UMMA is far broader, holding 95 positions to 32 for JGQYX, so beyond the top names it adds exposure JGQYX doesn't have.
UMMA is cheaper at 0.65% vs 1% — a difference of $35 a year per $10,000 invested.
Over one year, UMMA returned +26.5% vs +10.2% for JGQYX.
Updated Nov 19, 2026
UMMA vs JGQYX side by side
| UMMA | JGQYX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Roundhill | Jensen |
| Category | Global Stock | Global Stock |
| Expense ratio | 0.65% | 1% |
| Annual cost per $10k | $65 | $100 |
| 10-yr cost on $10k (prospectus) | $810 | $1,363 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +26.5% | +10.2% |
| 5-yr return (annualized) | — | +7.9% |
| 10-yr return (annualized) | — | — |
| Best quarter | +13.5% | — |
| Worst quarter | −8.0% | — |
| Net assets (fund) | $280.5M | $76.5M |
| Number of holdings | 95 | 32 |
| Portfolio turnover | 11% | 32% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
4 of UMMA's top 25 holdings also appear in JGQYX's top 25.
| Holding | UMMA | JGQYX |
|---|---|---|
| Tsmc | 10.04% | 8.75% |
| ASML Holding NV | 5.32% | 5.31% |
| AstraZeneca PLC | 2.56% | 3.80% |
| Sap Se | 1.61% | 2.06% |
Source: SEC Form N-PORT
UMMA top 10
- Tsmc — 10.04%
- Samsung Electronics Co Ltd — 8.24%
- SK hynix Inc — 8.14%
- ASML Holding NV — 5.32%
- Infineon Technologies AG — 4.19%
- Murata Manufacturing Co Ltd — 3.04%
- AstraZeneca PLC — 2.56%
- Novartis AG — 2.51%
- Roche Holding AG — 2.46%
- Nestle SA — 2.27%
JGQYX top 10
- Tsmc — 8.75%
- Microsoft Corp — 7.19%
- Alphabet Inc — 7.04%
- Amazon.com Inc — 5.73%
- KLA Corp — 5.65%
- ASML Holding NV — 5.31%
- NVIDIA Corp — 5.23%
- Apple Inc — 4.50%
- Eli Lilly & Co — 4.22%
- Aon PLC — 3.98%
FAQ
What is the difference between UMMA and JGQYX?
Which is cheaper, UMMA or JGQYX?
Should I own both UMMA and JGQYX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.